BIO Taps Big Pharma Execs for Federal Comparative Effectiveness Research Board Nominations
This article was originally published in The Pink Sheet Daily
Executive Summary
Four of BIO's six nominations are also PhRMA's nominations for the Patient-Centered Outcomes Research Institute board of governors.
You may also be interested in...
Pfizer's Lewis-Hall To Represent Pharma Interests On PCORI Board
Freda Lewis-Hall was among nominations from both BIO and PhRMA to sit on governing board of new comparative effectiveness entity created under the health care reform law.
Pfizer's Lewis-Hall To Represent Pharma Interests On PCORI Board
Freda Lewis-Hall was among nominations from both BIO and PhRMA to sit on governing board of new comparative effectiveness entity created under the health care reform law.
PCORI Should Take Lead On Public CER Inventory, Pharma Groups Tell HHS
Development of a publicly available repository of comparative effectiveness research should grow out of the work of the soon-to-be established Patient Centered Outcomes Research Institute, groups representing pharmaceutical industry interests urged in recent comments to HHS